linjc16/ctgov huggingface dataset:
Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control

Study Overview
=================
Brief Summary
-----------------
This study planned to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control in symptomatic and asymptomatic participants. We will follow a cross-over study design to compare the effect of hip focused neuromuscular activation exercise or a sham exercise on foot posture and lower extremity biomechanics. Foot posture will be assessed by Navicular Drop Test (NDT), and lower extremity neuromuscular control will be assessed with Star Excursion Y-Balance Test (SEBT-Y) and Frontal Plane Projection Angle (FPPA) during single leg squat before and after the experiments. The results of this study may provide scientific knowledge for a kinetic chain approach during functional foot rehabilitation.

Official Title
-----------------
A Cross-over Study to Investigate the Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control

Conditions
-----------------
Exercise

Intervention / Treatment
-----------------
* Other: Exercise


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: To be included, participants should be between the ages of 18 and 45 years. Exclusion Criteria: Participants will be excluded from this study if they have a history of lower body trauma or surgery, or positive trendelenburg sign and slump test.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Crossover Assignment
Interventional Model Description: A cross-over study to investigate the effect of hip-focused neuromuscular activation exercise on foot posture and neuromuscular control
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Neuromuscular Exercise<br>Neuromuscular Exercise | Other: Exercise<br>* Hip focused Neuromuscular Activation Exercise<br>|
| No Intervention: Control<br>No intervention | |
| Sham Comparator: Sham Exercise<br>Sham Exercise | Other: Exercise<br>* Hip focused Neuromuscular Activation Exercise<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Navicular Drop Test | Navicular Drop Test | 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Star Excursion Y-Balance Test | Star Excursion Y-Balance Test | 1 year | 
| Frontal Plane Projection Angle | Frontal Plane Projection Angle | 1 year |
Experience in Being With Advanced Heart Failure Patients

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to explore the experience in being with advanced Heart failure patients.

Detailed Description
-----------------
The aim is to explore the experience of advanced Heart failure patients during the disease trajectory in Taiwan.

Official Title
-----------------
National Taipei University of Nursing and Health Science

Conditions
-----------------
Heart Failure

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: the patients' conscious must be clear, vital sign is stable, and can communicate in Mandarin Chinese or Taiwanese. exclusion criteria: consciousness is unclear and can't have effective communication to interviewer. the patient reject to join this study.

Ages Eligible for Study
-----------------
Minimum Age: 20 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| advanced heart failure<br>the patients was diagnostic on Chronic heart failure with NYHA class 3 and 4, AHA stage D, or LVEF<40%. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| A qualitative research to decribe the experience with advanced Heart failure patients | describe patterns of diseases traits | participants will be followed for the duration of hospital stay, an expected average of 6 weeks. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Advanced heart failure, diseased experience
Post-traumatic Stress Disorder After Pediatric Intensive Care Unit Hospitalization

Study Overview
=================
Brief Summary
-----------------
The elements that promote the development of post-traumatic stress in parents following hospitalization in pediatric resuscitation and thus the options for improving initial care at the time of hospitalization are unknown. It is therefore important to describe the prevalence of post-traumatic stress disorder with current pediatric resuscitation management data, but also to possibly describe the factors associated with it in order to optimize initial management.

Official Title
-----------------
Post-traumatic Stress Disorder Occurrence in Parents of Neonate and Children Hospitalized in an Intensive Care Unit

Conditions
-----------------
Post-traumatic Stress

Intervention / Treatment
-----------------
* Other: Post traumatic stress disorder questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: - All parents of children aged 0 to 18 who have been admitted in paediatric resuscitation unit. Exclusion Criteria: Holders of parental authority who cannot answer the questionnaire because they do not speak French. Opposition of one of the two holders of parental authority Minor parental authority holders Holders of parental authority under safeguarding of justice or guardianship

Ages Eligible for Study
-----------------
Maximum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Questionary<br>Questionary for all parents | Other: Post traumatic stress disorder questionnaire<br>* Parents of hospitalized children in pediatric resuscitation carry out a validated questionnaire that validates the post-traumatic stress level by a score.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of post-traumatic stress disorder among parents of newborns, infants and children who have been hospitalized in a paediatric resuscitation unit. | Parents will complete Post-traumatic stress disorder Checklist. We will consider subjects with a score above 44 to be clinically affected by post-traumatic stress disorder. | Between one and 6 months after hospitalization. |
Effect of Single Colonoscopy on Colorectal Adenomas Detection

Study Overview
=================
Brief Summary
-----------------
Individualized colonoscopy withdrawal time is determined based on the different grade of physician experience and quality of bowel preparation.

Official Title
-----------------
Clinical Study That Effect of Individualized Intervention of Single Colonoscopy on Colorectal Adenomas Detection

Conditions
-----------------
Colonic Polyps

Intervention / Treatment
-----------------
* Other: doctor experience


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Greater than the age of 40; Pathology and endoscopic data recorded available and detailed; Whole bowel staining endoscopy is not done. Exclusion Criteria: Not reach the ileocecal junction; Colorectal cancer; Familial adenomatous polyposis; Inflammatory bowel disease; Part of the bowel resection.

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| A group<br>Experience of endoscopist: >2000 cases | Other: doctor experience<br> <br> |
| B group<br>Experience of endoscopist:between 1000 and 2000 cases | Other: doctor experience<br> <br> |
| C group<br>Experience of endoscopist:between 500 and 1000 cases | Other: doctor experience<br> <br> |
| D group<br>Experience of endoscopist:<500 cases | Other: doctor experience<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Detection rate of polyps in different withdraw time |  | through study completion, an average of 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Detection rate of polyps in different experiment levels of examiners |  | through study completion, an average of 1 year |
Musculo-scrawny Manifestation Associated With the Endometriosis

Study Overview
=================
Brief Summary
-----------------
The endometriosis is defined by the presence of endometriosic tissue outside of the womb and the prevalence is estimated to be 10% of women.Here is a project aimed to compare musculo-scrawny pains between patients with endometriosis and whose don't suffer of this pathology;

Official Title
-----------------
Musculo-scrawny Manifestation Associated With the Endometriosis

Conditions
-----------------
Endometriosis

Intervention / Treatment
-----------------
* Other: pain VAS evaluation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: age between 18 and 45 consulting in Service of gynecology First trimester of pregnancy or for pap smears Exclusion Criteria: endometriosis diagnostic already done rhumalogic disease known age < 18 and > 50 menopause

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: pain VAS evaluation|each patient has to answer to a questionnaire about pain|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| VAS of musculo-scrawny pain |  | Day 1 |
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation

Study Overview
=================
Brief Summary
-----------------
Recent experimental and clinical studies have shown that platelets play a critical role in liver ischemia and regeneration. Thrombocytopenia, a frequent and potentially serious condition in liver transplantation (LT) recipients, was shown to be associated with postoperative morbidity and mortality after partial hepatectomy. The investigators aim at evaluating whether postoperative low platelet counts are indicators of short- and long-term outcomes after liver transplantation.

Official Title
-----------------
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation

Conditions
-----------------
Complication, Death

Intervention / Treatment
-----------------
* Procedure: Liver transplantation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age >18 years old End stage liver disease Cadaveric-donor liver transplantation Exclusion Criteria: Age <18 years old Pregnancy Living-related liver transplantation

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Liver disease and liver transplantation<br>Patient with end stage liver disease and/or primary liver tumor undergoing liver transplantation | Procedure: Liver transplantation<br>* Standardized technique of liver transplantation Organ procurement follow the rules of the Swiss transplant society<br>* Other names: Cadaveric-donor liver transplantation;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Severe complication after liver transplantation | The severity of complications will be graded according to the Clavien-Dindo classification by outcome. Grade III to V complications will be considered as severe. | 90 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Primary graft non-function | Defined as death or retransplantation within the first postoperative week after exclusion of technical, immunological, and infectious causes | first postoperative week | 
| Delayed graft function | Defined as the presence of at least one of the following parameter at 7 days after LT: serum bilirubin > 10 mg/dL and International Normalized Ratio (INR) >1.6 or Alanine aminotransferase serum level (ALT) >2000UI/L | 7 days after liver transplantation | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Complications, Mortality, Liver transplantation, Platelet count, Survival
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality

Study Overview
=================
Brief Summary
-----------------
The purpose of this pilot study is to investigate the potential clinical benefits of combining two new diagnostic tools to provide co-registered anatomical and functional information in the breast in patients with suspected breast cancer.

Detailed Description
-----------------
The purpose of this pilot study is to obtain preliminary data on a new way of imaging the breast that combines the benefits of a 3-D anatomical technique (Digital Tomosynthesis) with those of a functional imaging technique (Molecular Breast Imaging). Combining data from these 2 modalities would provide co-registered functional and anatomical information on the breast, in the same way that PET/CT does today in oncology. This should greatly facilitate the evaluation and biopsy of lesions seen on MBI but occult on conventional mammography.

Official Title
-----------------
Pilot Study to Evaluate the Incremental Diagnostic Value of a Combined Molecular Breast Imaging / Breast Tomosynthesis Modality

Conditions
-----------------
Breast Cancer

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: over the age of 25 enrolled in one of the following protocols: IRB # 08-005522: Evaluation of Molecular Breast Imaging in Patients with a High Likelihood of Ductal Carcinoma in Situ. 07-004241: Molecular Breast Imaging in the Preoperative Evaluation of Women with Biopsy Proven Breast Cancer. 1204-03: Evaluation of a Small Field of View Gamma Camera for Scintimammography in Patients with Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, and Lobular Carcinoma In Situ. 07-003397: Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation. 17-05: Determination of the Sensitivity of a Dual-Headed Small Field of View Gamma Camera for the Detection of Small Breast Lesions. Digital mammogram at the Mayo Clinic within the past 30 days Exclusion Criteria: They are unable to understand and sign the consent form They are pregnant or lactating They are physically unable to sit upright and still for 40 minutes. Recently enrolled on one of the ongoing tomosynthesis vs. mammography studies (rationale - avoid performing duplicate tomosynthesis studies in the same patient)

Ages Eligible for Study
-----------------
Minimum Age: 25 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Positive MBI scan<br>Women who are previously enrolled in an MBI study that present with a positive MBI scan. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
MBI, Molecular Breast Imaging, Breast Cancer, Positive Molecular Breast Imaging scan.
Establishment of a PDT Patient Registry

Study Overview
=================
Brief Summary
-----------------
This is a non-intervention patient registry to gather data on the use of photodynamic therapy under real-life conditions. It will involve up to 20 sites in USA.

Detailed Description
-----------------
The purpose of this patient registry is to collect information about a patient's cancer treatment, photodynamic therapy (PDT), used alone or in combination with surgery, chemotherapy and radiotherapy. Patients will be registered either before or after PDT is performed, regardless of the indication. Analysis of this information may help to refine the treatment care. Data collected in the registry includes patient characteristics/demographics, disease characteristics, treatment details (photodynamic therapy, radiation, chemotherapy, surgery, etc.), side effects, and survival outcomes. By participating in this registry, patients will not be asked to do anything that would not ordinarily be done as a matter of routine care including clinical assessments, laboratory tests, radiology procedures, and treatments. Information on disease, condition, and treatment will be recorded in the registry during routine visits.

Official Title
-----------------
Establishment of a Registry for Patients Treated With Photodynamic Therapy (PDT)

Conditions
-----------------
Lung Cancer

Intervention / Treatment
-----------------
* Other: No intervention


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All adult patients (≥ 18 years of age) treated with PDT. Women and men and members of all races and ethnic groups. Subjects may have received prior treatment for their cancer. Subjects to give a written informed consent for prospectively collected data. Exclusion Criteria: None.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: No intervention|There are no interventions associated with this registry as it is purely observational.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| PDT Outcome | Collection of information on patient characteristics, disease sites, and utilization of prior or combined treatments to evaluate the impact of these parameters on the treatment outcome | Up to 5-year follow-up | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
lung cancer, lung carcinoma, lung metastases, metastases
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to investigate features of patients with Eosinophilic Gastrointestinal Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone, including Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic Colitis (EC).

Detailed Description
-----------------
This retrospective chart review study will analyze the demographics, medical history, clinical features, and pathological data of patients with Eosinophilic Gastrointestinal Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone, including Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic Colitis (EC).

Official Title
-----------------
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort

Conditions
-----------------
Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Eosinophilic Colitis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diagnosis of an EGID including EG, EGE, and/or EC. Subjects with EoE can be included if they also have another EGID. Clinical symptoms of gastrointestinal dysfunction. Findings of increased eosinophils on tissue biopsy at the time of diagnosis, before treatment initiated. Exclusion of other causes of gastrointestinal eosinophilia. Exclusion Criteria: Gastrointestinal eosinophilia caused by another disorder. Diagnosis of EoE without another EGID. Insufficient medical record or pathology data available to support an EGID diagnosis.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mucosal eosinophilia (eos/hpf) | Mucosal eosinophil levels are measured as eosinophils per high power field (eos/hpf). The primary outcome measure is to determine the change in mucosal eosinophil level (eos/hpf) and to determine if the change in mucosal eosinophil level in eos/hpf correlates with other measures of disease activity. | Duration of funding, approximately 5 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Eosinophilic Gastrointestinal Disorders